BJP meet calls for boycott of Chinese goods

DHNS
August 7, 2017

Bengaluru, Aug 8: Amid the escalating tension on India-China border over the Doklam issue, the state BJP utilised its executive committee meeting on Sunday as a platform to give a call for boycott of Chinese goods and to go “swadeshi”.

Briefing reporters on the deliberations of the meeting in Bengaluru, BJP state general secretary and Lok Sabha member Shobha Karandlaje said the party was of the firm opinion that the security and interest of the nation cannot be compromised.

“Our party cadre will create awareness among the people about the problems caused by China at the border and the need to boycott Chinese goods. They will also persuade traders not to sell made-in-China goods,” she said.

Shobha said that even pooja items such as kumkum and camphor are being imported from China. “The economy of China is largely dependent on Indian markets. The BJP state executive meeting felt that we should boycott their products to teach the neighbouring country a lesson,” she said.

Shobha said the state executive meeting also felt that India should not hesitate to engage in a confrontation with China if the country’s security is threatened.

Comments

shamshuddin Mohammed
 - 
Monday, 7 Aug 2017

Dear BJP yens as per chinese product , only 3% of their product selling to india if you boycott chinese item there are nothing difference for their economy , even india importing  national flag from China , modi already ordered Sardar Vallababai patel Statue with a billion dollers, dear bjp yens dont make a drama with our indian citizens ,if you have guts send border to your goons from rss bd ect., they know whom to select in next election. good bye 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 7,2020

Kasaragod, Apr 7: The new COVID Hospital at the Kasaragod Medical College has started functioning, Chief Minister Pinarayi Vijayan said on Monday.

The new administrative block of Kasaragod Medical College was converted into a COVID-19 Hospital for providing better treatment facilities to the coronavirus patients, the Chief Minister said while addressing a press conference at the Government Secretariat.

Stating that the hospital was converted to a Corona Care Hospital in just four days, he said 200 beds and 10 ICU beds are now ready.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 7,2020

New Delhi, Jun 7: The Karnataka government has asked the railways to make announcements at originating stations that it was compulsory for passengers travelling to the state to register themselves on the ‘Seva Sindhu’ portal through which they can be tracked.

In a letter to Chairman Railway Board on Saturday, Chief Secretary of the state T M Vijay Bhaskar said many passengers are not aware of this mandatory rule of the southern state.

He said thousands of passengers are coming to Karnataka from New Delhi, Bihar, Maharashtra and other states through trains everyday, but most of them are not registered under the Seva Sindhu portal of the Government of Kamataka.

"If passengers are not registered under Seva Sindhu, the state will not be able to track them. Therefore, it is necessary to create awareness among the passengers regarding registration under the portal.

"Hence, it is requested to give instructions to origin railway stations to make announcements that ‘It is compulsory for all passengers travelling to Karnataka to register in Seva Sindhu portal. Otherwise they will not be allowed for home quarantine’, and also to give passengers awareness (about this) at the time of booking tickets,” Bhaskar said in his letter to the national transporter.

Seva Sindhu portal, under the control of the Karnataka government, provides various online services to the citizens of the state.

Currently, this portal is playing an important role in helping those stranded amid the COVID-19 pandemic to fill online registration forms for availing e-passes.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.